Home  »  Business   »  Looking Closely at the Growth Curve for Tenaya The...

Looking Closely at the Growth Curve for Tenaya Therapeutics Inc. (TNYA)

Tenaya Therapeutics Inc. (NASDAQ:TNYA) went down by -4.31% from its latest closing price compared to the recent 1-year high of $22.87. The company’s stock price has collected -23.51% of loss in the last five trading sessions. Barron’s reported on 11/05/21 that Gene Therapy Is a Huge Opportunity. It Pays to be Patient.

Is It Worth Investing in Tenaya Therapeutics Inc. (NASDAQ :TNYA) Right Now?

TNYA currently public float of 37.87M and currently shorts hold a 3.43% ratio of that float. Today, the average trading volume of TNYA was 219.17K shares.

Do You Own These 7 Inflation-Survival Stocks?

Inflation is still near 40-year highs and rising prices are putting a big dent in our wallets. Unless you find out how to protect your portfolio and outpace inflation, you'll keep being at the mercy of economic factors out of your control. Especially since the price of electricity, food, and shelter are creeping up higher than ever. In this special report, I detail 7 stocks to help you survive and thrive in today's market. They're backed by solid companies, positioned to profit during tough economic times, and offer out-sized dividends to help you outpace inflation.

Click here to get your free copy of the report

Sponsored

TNYA’s Market Performance

TNYA stocks went down by -23.51% for the week, with a monthly drop of -4.31% and a quarterly performance of -48.20%, while its annual performance rate touched -86.82%. The volatility ratio for the week stands at 11.77% while the volatility levels for the past 30 days are set at 15.60% for Tenaya Therapeutics Inc. The simple moving average for the period of the last 20 days is -1.99% for TNYA stocks with a simple moving average of -63.80% for the last 200 days.

Analysts’ Opinion of TNYA

Many brokerage firms have already submitted their reports for TNYA stocks, with H.C. Wainwright repeating the rating for TNYA by listing it as a “Buy.” The predicted price for TNYA in the upcoming period, according to H.C. Wainwright is $25 based on the research report published on June 15th of the current year 2022.

TNYA Trading at -13.09% from the 50-Day Moving Average

After a stumble in the market that brought TNYA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -89.33% of loss for the given period.

Volatility was left at 15.60%, however, over the last 30 days, the volatility rate increased by 11.77%, as shares sank -5.79% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -40.34% lower at present.

During the last 5 trading sessions, TNYA fell by -23.51%, which changed the moving average for the period of 200-days by -81.97% in comparison to the 20-day moving average, which settled at $2.48. In addition, Tenaya Therapeutics Inc. saw -87.12% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at TNYA starting from COLUMN GROUP III GP, LP, who purchase 9,615,384 shares at the price of $2.60 back on Nov 21. After this action, COLUMN GROUP III GP, LP now owns 9,615,384 shares of Tenaya Therapeutics Inc., valued at $24,999,998 using the latest closing price.

GOEDDEL DAVID V, the Director of Tenaya Therapeutics Inc., purchase 9,615,384 shares at $2.60 during a trade that took place back on Nov 21, which means that GOEDDEL DAVID V is holding 9,615,384 shares at $24,999,998 based on the most recent closing price.

Stock Fundamentals for TNYA

Equity return is now at value -49.10, with -43.20 for asset returns.

[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]